<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Zibb.com: Ford Motor Company (Industry News &amp; Blogs)</title><link>http://www.zibb.com/healthcare/theme/cq/Ford+Motor+Company</link><atom:link rel="self" type="application/rss+xml" href="http://www.zibb.com/healthcare/theme/cq/Ford+Motor+Company" /><description>
					Zibb. The Global business search engine.
				</description><language>
					en-US
				</language><webMaster>search@zibb.com (RB Search)</webMaster><copyright>Copyright (c) 2007 Reed Business Information. All rights reserved.</copyright><pubDate>Sun, 28 Jun 2009 21:56:01 GMT</pubDate><lastBuildDate>Sun, 28 Jun 2009 21:56:01 GMT</lastBuildDate><ttl>60</ttl><image><title>Zibb.com: Ford Motor Company (Industry News &amp; Blogs)
          </title><width>88</width><height>31</height><link>http://www.zibb.com/healthcare/theme/cq/Ford+Motor+Company</link><url>
						http://www.zibb.com/images/en/g_zibb_logo_beta.gif
					</url></image><item><title>Budco Earns World Excellence Award from Ford</title><link>http://www.prweb.com/releases/2009/06/prweb2583334.htm</link><description>PR: Budco, a leading fulfillment and direct marketing organization received a Gold World Excellence Award from Ford Motor Company. The award recognized Budco for helping Ford achieve superior quality, delivery and cost performance and for embracing the ONE Ford vision. Budco was one of only eleven</description><guid>http://www.prweb.com/releases/2009/06/prweb2583334.htm</guid><category domain="http://www.zibb.com">Ford Motor Company</category><pubDate>Sun, 28 Jun 2009 21:56:01 GMT</pubDate><source url="http://www.prweb.com" /></item><item><title>U.S. Physical Therapy, Inc. Q3 2008 Earnings Call Transcript</title><link>http://seekingalpha.com/article/107661-u-s-physical-therapy-inc-q3-2008-earnings-call-transcript?source=feed</link><description>U.S. Physical Therapy, Inc. (USPH)Q3 2008 Earnings Call TranscriptComplete Story &lt;a</description><guid>http://seekingalpha.com/article/107661-u-s-physical-therapy-inc-q3-2008-earnings-call-transcript?source=feed</guid><category domain="http://www.zibb.com">Ford Motor Company</category><pubDate>Mon, 24 Nov 2008 18:34:17 GMT</pubDate><source url="http://seekingalpha.com" /></item><item><title>Earnings Preview: Pfizer (at Seeking Alpha)</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=120kuf1pr/*http://seekingalpha.com/article/100741-earnings-preview-pfizer?source=yahoo</link><description>Analysts are looking for a profit of 60c on revenue of $12B. The consensus range is 55c to 63c for EPS, and revenue of $11.53B to $12.34B, according to First Call.</description><guid>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=120kuf1pr/*http://seekingalpha.com/article/100741-earnings-preview-pfizer?source=yahoo</guid><category domain="http://www.zibb.com">Ford Motor Company</category><pubDate>Mon, 20 Oct 2008 17:45:37 GMT</pubDate><source url="http://us.rd.yahoo.com" /></item><item><title>VIA Pharmaceuticals to Present at Merriman Curhan Ford's Investor...
      </title><link>http://rss.feedsportal.com/c/506/f/6822/s/1d895e6/l/0L0Sbioportfolio0O0Ccgi0Ebin0Cdialogserver0Bexe0DCMD0Fhit0BdisplayMdoc0GID0F1840A1740GHITNO0F110GMSIZE0F10A0A0A0GLANGUAGE0Fen0GFILE0Fdoc0BNEWSFEED0GSAVEQUERY0A0A0Fbiotechnology0J20Apharmaceutical0GSAVEPROP0A0A0FL0J3den0GSAVEDB0Fnews0GSAVEORGANISE0ICODED0FR0J3adate0GR0F1840A1740GTHISHREF0Fhttp0J3a0C0Cc0Bmoreover0N0Cclick0Chere0Bpl0J3fz15927615110J26amp0J3bz0J3d950A2422730GTHEHOST0Fsite0Kd0Bmoreover0Bcom/story01.htm</link><description>Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory</description><guid>http://rss.feedsportal.com/c/506/f/6822/s/1d895e6/l/0L0Sbioportfolio0O0Ccgi0Ebin0Cdialogserver0Bexe0DCMD0Fhit0BdisplayMdoc0GID0F1840A1740GHITNO0F110GMSIZE0F10A0A0A0GLANGUAGE0Fen0GFILE0Fdoc0BNEWSFEED0GSAVEQUERY0A0A0Fbiotechnology0J20Apharmaceutical0GSAVEPROP0A0A0FL0J3den0GSAVEDB0Fnews0GSAVEORGANISE0ICODED0FR0J3adate0GR0F1840A1740GTHISHREF0Fhttp0J3a0C0Cc0Bmoreover0N0Cclick0Chere0Bpl0J3fz15927615110J26amp0J3bz0J3d950A2422730GTHEHOST0Fsite0Kd0Bmoreover0Bcom/story01.htm</guid><category domain="http://www.zibb.com">Ford Motor Company</category><pubDate>Tue, 09 Sep 2008 12:38:36 GMT</pubDate><source url="http://rss.feedsportal.com" /></item><item><title>Orexigen And Its Obesity Bets (at CNBC)</title><link>http://www.cnbc.com/id/26544573/site/14081545?__source=yahoo|headline|quote|text|&amp;par=yahoo</link><description>After Medivation, I moved onto the Orexigen presentation. It's a company I profiled at when it had data on one of its fat-fighting drugs at last year's diabetes conference, so I wanted to check up on its progress.</description><guid>http://www.cnbc.com/id/26544573/site/14081545?__source=yahoo|headline|quote|text|&amp;par=yahoo</guid><category domain="http://www.zibb.com">Ford Motor Company</category><pubDate>Thu, 04 Sep 2008 15:24:52 GMT</pubDate><source url="http://www.cnbc.com" /></item><item><title>Alpharma rejects $1.4 billion bid from King (at MarketWatch)</title><link>http://www.marketwatch.com/news/story/alpharma-rejects-14-billion-bid/story.aspx?guid=%7B83F2C055%2DC4CD%2D48F1%2DA354%2DE19284AC48EC%7D&amp;siteid=yhoof</link><description>King Pharmaceuticals says fellow specialty-drug maker Alpharma has rejected its takeover bid of $1.4 billion in cash.</description><guid>http://www.marketwatch.com/news/story/alpharma-rejects-14-billion-bid/story.aspx?guid=%7B83F2C055%2DC4CD%2D48F1%2DA354%2DE19284AC48EC%7D&amp;siteid=yhoof</guid><category domain="http://www.zibb.com">Ford Motor Company</category><pubDate>Fri, 22 Aug 2008 13:57:00 GMT</pubDate><source url="http://www.marketwatch.com" /></item><item><title>Genentech Lifted by Avastin Sales</title><link>http://www.nytimes.com/2008/07/15/business/15gene.html?partner=rssnyt&amp;emc=rss</link><description>Genentech reported higher-than-expected quarterly sales of its most important product, the cancer drug Avastin, and raised its earnings outlook for the year.</description><guid>http://www.nytimes.com/2008/07/15/business/15gene.html?partner=rssnyt&amp;emc=rss</guid><category domain="http://www.zibb.com">Ford Motor Company</category><pubDate>Tue, 15 Jul 2008 03:54:42 GMT</pubDate><source url="http://www.nytimes.com" /></item><item><title>Amgen Shows Little Growth (at The Wall Street Journal Online)</title><link>http://online.wsj.com/article/SB120121084440914601.html?mod=yahoo_hs&amp;ru=yahoo</link><description>Amgen reported flat fourth-quarter earnings and issued a tepid 2008 forecast, but also announced positive test results for a new osteoporosis drug.</description><guid>http://online.wsj.com/article/SB120121084440914601.html?mod=yahoo_hs&amp;ru=yahoo</guid><category domain="http://www.zibb.com">Ford Motor Company</category><pubDate>Fri, 25 Jan 2008 03:18:00 GMT</pubDate><source url="http://online.wsj.com" /></item><item><title>Former ImClone CEO Sam Waksal: He's Baaaack! (at CNBC)</title><link>http://www.cnbc.com/id/26219223/?__source=yahoo|headline|quote|text|&amp;par=yahoo</link><description>Late last week I blogged that ImClone Systems founder and former CEO Sam Waksal was, according to a source, going to get out of a federal prison in Michigan and move into a halfway house in the Bronx between August 7th and the 14th.</description><guid>http://www.cnbc.com/id/26219223/?__source=yahoo|headline|quote|text|&amp;par=yahoo</guid><category domain="http://www.zibb.com">Ford Motor Company</category><pubDate>Mon, 18 Aug 2008 15:50:42 GMT</pubDate><source url="http://www.cnbc.com" /></item><item><title>Biotech Stocks: Drug stocks slip, Enzon rises on divestiture news...
      </title><link>http://www.marketwatch.com/news/story/drug-stocks-slip-enzon-rises/story.aspx?guid=%7B79206A62%2DAEC1%2D40E0%2DBD3D%2DE7A15C7DA856%7D&amp;siteid=yhoof</link><description>Drug stocks rise, with shares of Enzon Inc. climbing on news that the company is considering selling off part or all of its specialty pharmaceuticals business.</description><guid>http://www.marketwatch.com/news/story/drug-stocks-slip-enzon-rises/story.aspx?guid=%7B79206A62%2DAEC1%2D40E0%2DBD3D%2DE7A15C7DA856%7D&amp;siteid=yhoof</guid><category domain="http://www.zibb.com">Ford Motor Company</category><pubDate>Mon, 11 Aug 2008 14:15:00 GMT</pubDate><source url="http://www.marketwatch.com" /></item><item><title>ImClone Wants To Clone Itself? (at CNBC)</title><link>http://www.cnbc.com/id/26010032/site/14081545?__source=yahoo|headline|quote|text|&amp;par=yahoo</link><description>Just before the opening bell this morning ImClone Systems put out a clearly Carl Icahn-inspired press release regarding last week's $60-a-share buyout offer from Bristol-Myers Squibb.</description><guid>http://www.cnbc.com/id/26010032/site/14081545?__source=yahoo|headline|quote|text|&amp;par=yahoo</guid><category domain="http://www.zibb.com">Ford Motor Company</category><pubDate>Mon, 04 Aug 2008 14:31:04 GMT</pubDate><source url="http://www.cnbc.com" /></item><item><title>ImClone says Bristol-Myers bid is 'substantially' too low (at Mar...
      </title><link>http://www.marketwatch.com/News/Story/Story.aspx?guid=%7b22D6A3BF-49CF-4905-A3EF-D50441E16104%7d&amp;siteid=yhoof2</link><description>NEW YORK (MarketWatch) -- ImClone Systems Inc. said Monday it is forming a committee to study the $4.5 billion offer it received from Bristol-Myers Squibb Co. , but its board's preliminary view is that the offer substantially undervalues ImClone. ImClone said its board has been discussing the</description><guid>http://www.marketwatch.com/News/Story/Story.aspx?guid=%7b22D6A3BF-49CF-4905-A3EF-D50441E16104%7d&amp;siteid=yhoof2</guid><category domain="http://www.zibb.com">Ford Motor Company</category><pubDate>Mon, 04 Aug 2008 13:29:05 GMT</pubDate><source url="http://www.marketwatch.com" /></item><item><title>Bristol-Myers offers to buy all of ImClone shares for $4.5B (at M...
      </title><link>http://www.marketwatch.com/News/Story/Story.aspx?guid=%7b8392B98B-847F-4B9B-894D-8C79BC62E3D0%7d&amp;siteid=yhoof2</link><description>NEW YORK (MarketWatch) -- Bristol-Myers Squibb Co. has offered to purchase the remaining shares of ImClone for $4.5 billion, or $60 each. The offer price represents a 29% premium to ImClone's closing price on Wednesday at $46.44. New York pharmaceutical provider Bristol-Myers already owns 17% of</description><guid>http://www.marketwatch.com/News/Story/Story.aspx?guid=%7b8392B98B-847F-4B9B-894D-8C79BC62E3D0%7d&amp;siteid=yhoof2</guid><category domain="http://www.zibb.com">Ford Motor Company</category><pubDate>Thu, 31 Jul 2008 12:16:03 GMT</pubDate><source url="http://www.marketwatch.com" /></item><item><title>Wyeth profit crimped by generic competition, restructuring (at Ma...
      </title><link>http://www.marketwatch.com/news/story/wyeth-profit-crimped-generic-competition/story.aspx?guid=%7BE8E00970%2D14E8%2D44C0%2D97D6%2DB8DCC79F6ACA%7D&amp;siteid=yhoof</link><description>Wyeth raises its full-year forecast but reports modestly lower second-quarter earnings, due in part to restructuring costs and increased generic competition for its popular heartburn medication Protonix.</description><guid>http://www.marketwatch.com/news/story/wyeth-profit-crimped-generic-competition/story.aspx?guid=%7BE8E00970%2D14E8%2D44C0%2D97D6%2DB8DCC79F6ACA%7D&amp;siteid=yhoof</guid><category domain="http://www.zibb.com">Ford Motor Company</category><pubDate>Wed, 23 Jul 2008 14:56:00 GMT</pubDate><source url="http://www.marketwatch.com" /></item><item><title>Pfizer's profit doubles on lower costs, favorable exchange rate (...
      </title><link>http://www.marketwatch.com/news/story/pfizers-profit-doubles-lower-costs/story.aspx?guid=%7B7DBD6668%2D1B54%2D449D%2DB84B%2D0549C8D5E912%7D&amp;siteid=yhoof</link><description>Pfizer, the world’s largest drugmaker, reports that its second-quarter profit more than doubled, due largely to a favorable currency exchange rate and lower costs.</description><guid>http://www.marketwatch.com/news/story/pfizers-profit-doubles-lower-costs/story.aspx?guid=%7B7DBD6668%2D1B54%2D449D%2DB84B%2D0549C8D5E912%7D&amp;siteid=yhoof</guid><category domain="http://www.zibb.com">Ford Motor Company</category><pubDate>Wed, 23 Jul 2008 11:59:00 GMT</pubDate><source url="http://www.marketwatch.com" /></item><item><title>U.S. Physical Therapy Flexes Some Muscle</title><link>http://seekingalpha.com/article/74031-u-s-physical-therapy-flexes-some-muscle?source=feed</link><description>Howâ€™s the ankle feeling today? Still a wee bit sore from last weekendâ€™spickup basketball game? Does the shoulder feel funny since you liftedthat crate at work?If youâ€™re starting to feel your age, then letâ€™s get physical â€” therapy, that is. &lt;a</description><guid>http://seekingalpha.com/article/74031-u-s-physical-therapy-flexes-some-muscle?source=feed</guid><category domain="http://www.zibb.com">Ford Motor Company</category><pubDate>Fri, 25 Apr 2008 08:56:49 GMT</pubDate><source url="http://seekingalpha.com" /></item><item><title>The Wrinkle in Allergan's Earnings (at CNBC)</title><link>http://www.cnbc.com/id/24505500/?__source=yahoo|headline|quote|text|&amp;par=yahoo</link><description>One small detail took the stock down Wednesday. Cramer called the CEO to put it in perspective.</description><guid>http://www.cnbc.com/id/24505500/?__source=yahoo|headline|quote|text|&amp;par=yahoo</guid><category domain="http://www.zibb.com">Ford Motor Company</category><pubDate>Wed, 07 May 2008 22:43:26 GMT</pubDate><source url="http://www.cnbc.com" /></item><item><title>Merck's Outlook Falls Short of Expectations (at The Wall Street J...
      </title><link>http://online.wsj.com/article/SB119677253546213061.html?mod=yahoo_hs&amp;ru=yahoo</link><description>Merck issued a conservative profit forecast for 2008, as it faces generic challenges to osteoporosis drug Fosamax. (Conference call transcript)</description><guid>http://online.wsj.com/article/SB119677253546213061.html?mod=yahoo_hs&amp;ru=yahoo</guid><category domain="http://www.zibb.com">Ford Motor Company</category><pubDate>Tue, 04 Dec 2007 14:54:00 GMT</pubDate><source url="http://online.wsj.com" /></item><item><title>Merck and Schering-Plough to delay results for Vytorin data (at M...
      </title><link>http://www.marketwatch.com/news/story/merck-schering-plough-delay-results-vytorin/story.aspx?guid=%7BAD9785F3%2D60C0%2D494F%2DA620%2DA0070450871C%7D&amp;siteid=yhoof</link><description>Anti-cholesterol agent jointly sold by Merck &amp; Co. and Schering-Plough Corp. failed to show it was effective in stopping progression of arterial blockage, researchers say.</description><guid>http://www.marketwatch.com/news/story/merck-schering-plough-delay-results-vytorin/story.aspx?guid=%7BAD9785F3%2D60C0%2D494F%2DA620%2DA0070450871C%7D&amp;siteid=yhoof</guid><category domain="http://www.zibb.com">Ford Motor Company</category><pubDate>Mon, 21 Jul 2008 12:48:00 GMT</pubDate><source url="http://www.marketwatch.com" /></item></channel></rss>